Why is Evoq Remedies falling/rising?

As of 15-Sep, Evoq Remedies Ltd is currently priced at 3.62, reflecting a decrease of 0.07 or 1.9%. The stock has underperformed its sector by 1.45% today and is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. Additionally, there has been a significant decline in investor participation, with delivery volume dropping by 64.29% compared to the 5-day average. Over the past week, the stock has seen a substantial decline of 9.50%, and year-to-date, it has fallen by 53.59%. Unfortunately, there is no information available regarding positive or negative factors that could influence the stock's recent movement.
In the broader market context, the Sensex has shown a positive return of 1.24% over the past week, contrasting sharply with Evoq Remedies' decline. This underperformance is further highlighted by the stock's year-to-date return of -53.59% compared to the Sensex's gain of 4.67%. The stark difference in performance indicates that while the broader market is experiencing growth, Evoq Remedies is struggling significantly, which may be contributing to the downward pressure on its stock price.